(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPHTHALIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPHTHALIN

ST13

US500000090385819

Class

5

Filing

90385819

Registration

6860398

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

09/27/2022

Trademark type

Word

Nice classes

5

Filing date

12/16/2020

Registration date

09/27/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/27/2022

Last transaction

09/27/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-04-00

First use in commerce

2022-04-00

Drawing code

4

Owner type

03

Owner location

Jena, DE

Examiner

BROWNING, LUKE CASH

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Carl Zeiss Meditec AG

Representatives

Ronald S. Kadden Leydig, Voit & Mayer, Ltd.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Sterile solutions used in ophthalmic surgery to protect the inner lining of the cornea and maintain the front chamber of the opened eye; injectable solutions used in ophthalmic surgery to protect the inner lining of the cornea and maintain the front chamber of the opened eye

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/27/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/23/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/22/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/19/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/17/2022

IUAF

USE AMENDMENT FILED

08/02/2022

EISU

TEAS STATEMENT OF USE RECEIVED

08/02/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/10/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/10/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/10/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/10/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/18/2021

EX1G

SOU EXTENSION 1 GRANTED

12/16/2021

EXT1

SOU EXTENSION 1 FILED

12/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

12/16/2021

DOCK

ASSIGNED TO EXAMINER

08/23/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/08/2021

PUBO

PUBLISHED FOR OPPOSITION

06/08/2021

DOCK

ASSIGNED TO EXAMINER

06/02/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/19/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/06/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

05/06/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/06/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

05/06/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/06/2021

DOCK

ASSIGNED TO EXAMINER

05/05/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/24/2021

NWAP

NEW APPLICATION ENTERED

12/19/2020

Continuous trademark protection

Get notified about every new filing that threatens OPHTHALIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.